|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 753.93 USD | -0.21% |
|
-2.79% | -2.32% |
| Capitalization | 77.37B 65.54B 60.43B 56.99B 106B 7,212B 108B 709B 277B 3,462B 290B 284B 12,293B | P/E ratio 2026 * |
19.2x | P/E ratio 2027 * | 15.8x |
|---|---|---|---|---|---|
| Enterprise value | 69.3B 58.7B 54.13B 51.04B 95.2B 6,459B 96.73B 635B 248B 3,101B 260B 255B 11,011B | EV / Sales 2026 * |
4.41x | EV / Sales 2027 * | 3.84x |
| Free-Float |
77.36% | Yield 2026 * |
0.52% | Yield 2027 * | 0.58% |
Last Transcript: Regeneron Pharmaceuticals, Inc.
| 1 day | -0.21% | ||
| 1 week | -2.79% | ||
| Current month | -2.42% | ||
| 1 month | +1.09% | ||
| 3 months | +1.62% | ||
| 6 months | +30.80% | ||
| Current year | -2.32% |
| 1 week | 737.34 |  | 771.48 |
| 1 month | 727.88 | | 781.21 |
| Current year | 718.38 | | 821.11 |
| 1 year | 476.49 | | 821.11 |
| 3 years | 476.49 | | 1,211.2 |
| 5 years | 476.49 | | 1,211.2 |
| 10 years | 271.37 | | 1,211.2 |
| Manager | Title | Age | Since |
|---|---|---|---|
| President | 66 | 2000-12-31 | |
| Chief Executive Officer | 73 | 1988-01-07 | |
| Director of Finance/CFO | 55 | 2024-02-04 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 73 | 2023-06-08 | |
Michael Brown
BRD | Director/Board Member | 85 | 1991-05-31 |
Joseph Goldstein
BRD | Director/Board Member | 85 | 1991-05-31 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.21% | -2.79% | +35.13% | -9.09% | 77.37B | |
| -1.81% | -0.78% | +86.46% | +202.96% | 59.71B | |
| +4.30% | +60.20% | +60.20% | +60.20% | 50.37B | |
| -1.44% | -2.01% | -43.19% | -54.48% | 47.92B | |
| +0.88% | +0.36% | +54.33% | -37.34% | 26.5B | |
| +2.69% | +4.15% | +106.78% | -65.46% | 21.52B | |
| -0.60% | +1.26% | +66.10% | +30.34% | 19.32B | |
| +0.24% | +1.28% | +54.65% | +52.59% | 15.55B | |
| -0.30% | +4.80% | +126.93% | +427.14% | 15.06B | |
| +5.67% | -0.40% | -1.84% | +609.13% | 13.56B | |
| Average | +0.55% | +1.31% | +54.56% | +121.60% | 34.69B | |
| Weighted average by Cap. | +0.24% | +0.12% | +47.84% | +73.61% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 15.71B 13.31B 12.27B 11.57B 21.58B 1,464B 21.93B 144B 56.33B 703B 58.94B 57.7B 2,496B | 17.32B 14.67B 13.53B 12.75B 23.79B 1,614B 24.17B 159B 62.09B 775B 64.97B 63.61B 2,751B |
| Net income | 4.22B 3.57B 3.29B 3.11B 5.79B 393B 5.89B 38.64B 15.12B 189B 15.82B 15.49B 670B | 5.31B 4.5B 4.15B 3.91B 7.3B 495B 7.42B 48.68B 19.05B 238B 19.93B 19.52B 844B |
| Net Debt | -8.07B -6.84B -6.31B -5.95B -11.09B -752B -11.27B -73.95B -28.95B -361B -30.29B -29.65B -1,283B | -10.92B -9.25B -8.53B -8.04B -15B -1,018B -15.24B -100B -39.15B -489B -40.96B -40.1B -1,735B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-04-15 | 753.93 $ | -0.21% | 571,179 |
| 26-04-14 | 755.51 $ | +1.21% | 637,779 |
| 26-04-13 | 746.46 $ | -0.32% | 747,093 |
| 26-04-10 | 748.87 $ | -2.47% | 751,457 |
| 26-04-09 | 767.85 $ | -0.99% | 596,831 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- REGN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition